@article{3030590, title = "Arterial biomarkers in the evaluation, management and prognosis of aortic stenosis", author = "Gardikioti, Vasiliki and Terentes-Printzios, Dimitrios and Iliopoulos, and Dimitrios and Aznaouridis, Konstantinos and Sigala, Evangelia and and Tsioufis, Konstantinos and Vlachopoulos, Charalambos", journal = "Atherosclerosis", year = "2021", volume = "332", pages = "1-15", publisher = "Elsevier Ireland Ltd", issn = "0021-9150", doi = "10.1016/j.atherosclerosis.2021.07.006", keywords = "Aortic valve stenosis; Arterial stiffness; Arterial biomarkers; Pulse wave velocity; Arterial compliance", abstract = "Degenerative aortic valve stenosis is the most common primary valve disease and a significant cause of cardiovascular morbidity and mortality. In an era when new techniques for the management of aortic stenosis are gaining ground, the understanding of this disease is more important than ever to optimize treatment. So far, the focus has been placed on the assessment of the valve itself. However, the role that the arterial system plays in the pathogenesis and natural history of the disease needs to be further elucidated. Arteriosclerosis, when it coexists with a stenotic valve, augments the load posed on the left ventricle contributing to greater impairment of cardiovascular function. Arterial stiffness, a well-established predictor for cardiovascular disease and all-cause mortality, could play a role in the prognosis and quality of life of this population. Several studies using a variety of indices to assess arterial stiffness have tried to address the potential utility of arterial function assessment in the case of aortic stenosis. Importantly, reliable data identify a prognostic role of arterial biomarkers in aortic stenosis and stress their possible use to optimize timing and method of treatment. This review aims at summarizing the existing knowledge on the interplay between the heart and the vessels in the presence of degenerative aortic stenosis, prior, upon and after interventional management. Further, it discusses the evidence supporting the potential clinical application of arterial biomarkers for the assessment of progression, severity, management and prognosis of aortic stenosis." }